JP2020517643A5 - - Google Patents

Download PDF

Info

Publication number
JP2020517643A5
JP2020517643A5 JP2019556909A JP2019556909A JP2020517643A5 JP 2020517643 A5 JP2020517643 A5 JP 2020517643A5 JP 2019556909 A JP2019556909 A JP 2019556909A JP 2019556909 A JP2019556909 A JP 2019556909A JP 2020517643 A5 JP2020517643 A5 JP 2020517643A5
Authority
JP
Japan
Prior art keywords
protein
sequence
complement
seq
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019556909A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020517643A (ja
JP7153669B2 (ja
Filing date
Publication date
Priority claimed from GBGB1706406.4A external-priority patent/GB201706406D0/en
Priority claimed from GBGB1706398.3A external-priority patent/GB201706398D0/en
Application filed filed Critical
Priority claimed from PCT/EP2018/060239 external-priority patent/WO2018193120A1/en
Publication of JP2020517643A publication Critical patent/JP2020517643A/ja
Publication of JP2020517643A5 publication Critical patent/JP2020517643A5/ja
Priority to JP2022159216A priority Critical patent/JP2022188170A/ja
Application granted granted Critical
Publication of JP7153669B2 publication Critical patent/JP7153669B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019556909A 2017-04-21 2018-04-20 瘢痕性眼炎症障害の治療のためのコバーシン Active JP7153669B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022159216A JP2022188170A (ja) 2017-04-21 2022-10-03 瘢痕性眼炎症障害の治療のためのコバーシン

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1706406.4A GB201706406D0 (en) 2017-04-21 2017-04-21 Method of treatment
GB1706398.3 2017-04-21
GBGB1706398.3A GB201706398D0 (en) 2017-04-21 2017-04-21 Method of treatment
GB1706406.4 2017-04-21
PCT/EP2018/060239 WO2018193120A1 (en) 2017-04-21 2018-04-20 Coversin for the treatment of cicatrising eye inflammatory disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022159216A Division JP2022188170A (ja) 2017-04-21 2022-10-03 瘢痕性眼炎症障害の治療のためのコバーシン

Publications (3)

Publication Number Publication Date
JP2020517643A JP2020517643A (ja) 2020-06-18
JP2020517643A5 true JP2020517643A5 (https=) 2021-05-27
JP7153669B2 JP7153669B2 (ja) 2022-10-14

Family

ID=62028030

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019556909A Active JP7153669B2 (ja) 2017-04-21 2018-04-20 瘢痕性眼炎症障害の治療のためのコバーシン
JP2022159216A Ceased JP2022188170A (ja) 2017-04-21 2022-10-03 瘢痕性眼炎症障害の治療のためのコバーシン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022159216A Ceased JP2022188170A (ja) 2017-04-21 2022-10-03 瘢痕性眼炎症障害の治療のためのコバーシン

Country Status (8)

Country Link
US (1) US20210113658A1 (https=)
EP (1) EP3612206A1 (https=)
JP (2) JP7153669B2 (https=)
KR (1) KR20190138650A (https=)
CN (1) CN110831617A (https=)
AU (1) AU2018253960A1 (https=)
CA (1) CA3060331A1 (https=)
WO (1) WO2018193120A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2945433T3 (es) 2017-04-21 2023-07-03 Volution Immuno Pharmaceuticals Sa Coversina para el tratamiento de enfermedades ampollares autoinmunes
GB201706406D0 (en) * 2017-04-21 2017-06-07 Volution Immuno Pharmaceuticals Sa Method of treatment
GB201905810D0 (en) * 2019-04-25 2019-06-05 Volution Immuno Pharmaceuticals Sa Method of treatment
JP2023503776A (ja) 2019-09-27 2023-02-01 ヴォリューション イミュノ ファーマシューティカルズ エスエイ 造血幹細胞移植後の血栓性微小血管症（ｈｓｃｔ－ｔｍａ）の治療方法
EP4527584A4 (en) 2022-05-18 2025-08-20 Asahi Chemical Ind PROCESS FOR PRODUCING A RESIN COMPOSITION
GB202218084D0 (en) 2022-12-01 2023-01-18 Volution Immuno Pharmaceuticals Sa Fusion proteins
GB202408081D0 (en) 2024-06-06 2024-07-24 Volution Immuno Pharmaceuticals Sa Methods of removing impurities

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1739078A1 (de) * 2005-05-30 2007-01-03 Jerini AG C5a-Rezeptor-Antagonisten
PL2061501T3 (pl) * 2006-09-08 2016-01-29 Volution Immuno Pharmaceuticals Sa Sposób leczenia zaburzeń oddechowych
JP2010521194A (ja) * 2007-03-22 2010-06-24 ノバルティス アーゲー Ｃ５抗原およびその使用
GB0802116D0 (en) * 2008-02-05 2008-03-12 Natural Enviromental Res Counc Treatment
WO2011056972A2 (en) * 2009-11-04 2011-05-12 Case Western Reserve University Compositions and methods of treating a t cell mediated disorder
GB0906779D0 (en) * 2009-04-20 2009-06-03 Natural Environment Res Council Composition
US20110077270A1 (en) * 2009-04-21 2011-03-31 Pfeffer Bruce A Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
CN103796667A (zh) * 2011-06-22 2014-05-14 艾普莱斯制药公司 用补体抑制剂治疗慢性障碍的方法
WO2015134673A1 (en) * 2014-03-04 2015-09-11 The Trustees Of Columbia University In The City Of New York Method for treating ocular inflammation
GB201410031D0 (en) * 2014-06-05 2014-07-16 Isis Innovation Polypeptides and uses thereof
GB201410116D0 (en) * 2014-06-06 2014-07-23 Volution Immuno Pharmaceuticals Sa Method of treatment
EP3250230B9 (en) * 2015-01-28 2022-02-23 RA Pharmaceuticals, Inc. Modulators of complement activity
ES2945433T3 (es) 2017-04-21 2023-07-03 Volution Immuno Pharmaceuticals Sa Coversina para el tratamiento de enfermedades ampollares autoinmunes
GB201706406D0 (en) 2017-04-21 2017-06-07 Volution Immuno Pharmaceuticals Sa Method of treatment

Similar Documents

Publication Publication Date Title
JP2020517643A5 (https=)
JP2016509011A5 (https=)
JP2016529229A5 (https=)
ES2563646T3 (es) Composiciones y métodos relacionados con variantes de la proteína A (SpA)
EA202191418A1 (ru) Рекомбинантные вирусные векторы и нуклеиновые кислоты для их получения
NZ789212A (en) Anti-c5 antibodies and methods of use
JP2018511327A5 (https=)
JP2015522576A5 (https=)
JP2018522563A5 (https=)
JP2012507271A5 (https=)
JP2019506166A5 (https=)
JP2008508859A5 (https=)
FI3352776T3 (fi) Htt-repressoreita ja niiden käyttötapoja
JP2019520550A5 (https=)
JP2013534812A5 (https=)
EP2532366A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF CANCER
JP2015532644A5 (https=)
NZ591130A (en) Compositions comprising a PD-1 antagonists and cyclophosphamide and methods of use thereof
JP2017521074A5 (https=)
JP2019510739A5 (https=)
JP2018537089A5 (https=)
JPWO2019156137A5 (https=)
JP2015514132A5 (https=)
JP2017531613A5 (https=)
IL276158B1 (en) Methods and compositions for treatment of angiogenic disorders using anti-vegf agents